hotspot -WSS

hotspot

author：comprehensive 2025-09-03 03:31:15 - browse：9663

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： EF3 tornado rips through North Carolina amid extreme weather nationwide

knowledge

WSS

WATCH: Why do our ears pop?

Secretariat’s lessons for human medicine

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Awakening the world to the whoosh: A patient's crusade

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Medicare Advantage enrollment grows 7.1% to 33.4 million people

focus

hotspot

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Why Congress must ban federal programs from using QALYs

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

New air purifier tech could be key to improving indoor air quality

In 'major milestone,' FDA approves first cell therapy for solid tumors

How one medical school became remarkably diverse

Flagship Pioneering startup Sonata Therapeutics lays off 21

In Memoriam: Notable people who died in 2023

Opioid cravings were reduced by anti

explore

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Secretariat’s lessons for human medicine

FDA warns medical device makers about rise in fabricated data

I learned firsthand about improving diversity in clinical trials

Stanford president faces new allegations over 1999 paper

knowledge

leisure time

knowledge

hotspot